Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
TRIAMCINOLONE ACETONIDE
Nasacort AQ
Allergic Rhinitis
XRG5029C_4007NASummary
TRKA INHIBITOR
Not marketed
Osteoarthritis
TDU13828 / ACT13830NAEudraCT: 2014-004805-34Summary
TRPV3 ANTAGONIST
Not marketed
Neuropathic pain
ACT11917ALCHEMILLAsummary on EudraCT: 2011-001876-21Summary Results Posted
TRPV3 ANTAGONIST
Not marketed
Neuropathic pain
ACT11917ALCHEMILLAsummary on EudraCT: 2011-001876-21Summary Results Posted
TUSAMITAMAB RAVTANSINE
Not marketed
non-squamous non–small-cell lung cancer (NSQ NSCLC)
ACT16146CARMEN-LC05NCT04524689Tabulated Results
TUSAMITAMAB RAVTANSINE
Not marketed
Adenocarcinoma gastric Gastrooesophageal cancer
ACT16444CARMEN-GC01NCT05071053Tabulated Results
TUSAMITAMAB RAVTANSINE
Not marketed
Non-small cell lung cancer metastatic
ACT16525CARMEN-LC04NCT04394624Tabulated Results
TUSAMITAMAB RAVTANSINE
Not marketed
Non-squamous Non-small Cell Lung Cancer
ACT17241CARMEN-LC06NCT05245071Tabulated Results
TUSAMITAMAB RAVTANSINE
Not marketed
Neoplasm malignant
TCD15054NANCT03324113Publication
TUSAMITAMAB RAVTANSINE
Not marketed
Neoplasm malignant
TED13751NANCT02187848Publication

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted